Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine vs Levocetirizine + Hydroxyzine in Severe Chronic Urticaria
NCT01250652Phase 4Completed
- Sponsor
- American Lung Association
- Start
- Mar 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxyzine in chronic urticaria (CU), sponsored by American Lung Association. Started Mar 2011; status: completed.
02
Drugs
hydroxyzine
03
Conditions
chronic urticaria (CU)
Beyond the preview
Go deeper on NCT01250652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250652.